Noticias de TENX_US

Noticias del mercado

Últimas noticias sobre TENX_US — 181 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: TENX_US ✕ 181 resultados
19/06/2026 TENX_US — TradingKey ES ← EN
Valoración de Tenax Therapeutics Inc (TENX): PE, PB y análisis de valor razonable

Tenax Therapeutics Inc (TENX) Valuation: PE, PB & Fair Value Analysis

19/06/2026 TENX_US — TradingKey ES ← EN
Evaluación de riesgos de Tenax Therapeutics Inc (TENX): volatilidad, riesgo financiero y riesgo de inversión

Tenax Therapeutics Inc (TENX) Risk Assessment: Volatility, Financial Risk & Investment Risk

18/06/2026 TENX_US — TradingKey ES ← EN
Dividendos y divisiones de acciones de Tenax Therapeutics Inc (TENX): pagos históricos y cronograma de eventos

Tenax Therapeutics Inc (TENX) Dividends & Stock Splits: Historical Payouts and Event Timeline

18/06/2026 TENX_US — TradingKey
Tenax Therapeutics Inc (TENX) Technical Analysis: Support, Resistance, Indicators & Moving Averages
18/06/2026 TENX_US — TradingKey
Tenax Therapeutics Inc (TENX) Financial Health: Profitability & Balance Sheet Analysis
17/06/2026 TENX_US — TradingKey
Tenax Therapeutics Inc (TENX) Shareholder Structure: Major Shareholders & Institutional Holdings
17/06/2026 TENX_US — TradingKey
Tenax Therapeutics Inc (TENX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
17/06/2026 TENX_US — newsline.com ES ← EN
Tenax Therapeutics (TENX) aumenta un 4,8% a medida que el impulso aumenta por encima del soporte clave: factor de calidad de las ganancias

Tenax Therapeutics (TENX) Surges 4.8% as Momentum Builds Above Key Support - Earnings Quality Factor

16/06/2026 TENX_US — TradingKey
Tenax Therapeutics Inc (TENX) Institutional Confidence
12/06/2026 TENX_US — GuruFocus
TENX Maintained by Piper Sandler -- Price Target Raised to $50
12/06/2026 TENX_US — newsline.com
Tenax Therapeutics Q1 2026 Earnings: Narrower-than-Expected Loss Lifts Shares - Earnings Season Outlook
12/06/2026 TENX_US — newsline.com ES ← EN
Ganancias de Tenax Therapeutics del primer trimestre de 2026: una pérdida menor de lo esperado eleva las acciones - Estimación futura de EPS

Tenax Therapeutics Q1 2026 Earnings: Narrower-than-Expected Loss Lifts Shares - Forward EPS Estimate

12/06/2026 TENX_US — GuruFocus ES ← EN
TENX mantenido por Piper Sandler - Precio objetivo elevado a $50

TENX Maintained by Piper Sandler -- Price Target Raised to $50

07/06/2026 TENX_US — newsline.com
Tenax Therapeutics (TENX) Slips 3.25% as Stock Tests Key Support Levels - Merger Arbitrage
05/06/2026 TENX_US — Stock Titan
T. Rowe Price discloses 586,990 Tenax shares (NASDAQ: TENX) in amended 13G
04/06/2026 TENX_US — TipRanks
Tenax Therapeutics Announces Results of 2026 Annual Meeting
04/06/2026 TENX_US — Stock Titan
Tenax Therapeutics (TENX) shareholders elect full board, ratify 2026 auditor
31/05/2026 TENX_US — newsline.com
Tenax Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock Reaction - GAAP Earnings Report
31/05/2026 TENX_US — newsline.com
Tenax Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock Reaction
30/05/2026 TENX_US — Stock Traders Daily
Why (TENX) Price Action Is Critical for Tactical Trading

Sólo acción del precio: los movimientos de Tenax Therapeutics Inc. (TENX) marcan la pauta para los modelos institucionales. Por qué la acción del precio (TENX) es fundamental para el comercio táctico

Página 1 de 10

keyboard_arrow_up